title: Presentation of retinoblastoma patients in Malaysia.
abstract: BACKGROUND
  Retinoblastoma is a rare type of cancer that usually develops in early childhood. If left untreated it can cause blindness and even death. The aim of this study is to determine sociodemographic and clinical features of retinoblastoma patients and also to determine the treatment pattern and outcome in Malaysia.
  
  
  METHODS
  Data for this study were retrieved from the Retinoblastoma Registry of the National Eye Database (NED) in Malaysia. Hospital Kuala Lumpur, Hospital Umum Kuching, Sarawak and Hospital Queen Elizabeth, Kota Kinabalu were the major source data providers for this study. Data collected in the registry cover demography, clinical presentation, modes of treatment, outcomes and complications.
  
  
  RESULTS
  The study group consisted of 119 patients (162 eyes) diagnosed with retinoblastoma between 2004 and 2012. There were 68 male (57.1%) and 51 (42.9%) female. The median age at presentation was 22 months. A majority of patients were Malays (54.6%), followed by Chinese (18, 5%), Indians (8.4%), and indigenous races (15.9%). Seventy six (63.8%) patients had unilateral involvement whereas 43 patients had bilateral disease (36.1%). It was found that most children presented with leukocoria (110 patients), followed by strabismus (19), and protopsis (12). Among the 76 with unilateral involvement (76 eyes), enucleation was performed for a majority (79%). More than half of these patients had extraocular extension. Of the 40 who received chemotherapy, 95% were given drugs systemically. Furthermore, in 43 patients with bilateral involvement (86 eyes), 35 (41%) eyes were enucleated and 17 (49%) showed extraocular extension. Seventy-two percent of these patients received systemic chemotherapy. The patients were followed up 1 year after diagnosis, whereby 66 were found to be alive and 4 dead. Sixteen patients defaulted treatment and were lost to follow-up, whereas follow-up data were not available in 33 patients.
  
  
  CONCLUSIONS
  Patients with retinoblastoma in this middle-income Asian setting are presenting at late stages. As a result, a high proportion of patients warrant aggressive management such as enucleation. We also showed that a high number of patients default follow-up. Therefore, reduction in refusal or delay to initial treatment, and follow-up should be emphasized in order to improve the survival rates of retinoblastoma in this part of the world.
authors.affiliation: National Clinical Research Centre, Dermatology Block, Hospital Kuala Lumpur, Jalan Pahang, Malaysia E-mail : jamalia.rahmat@gmail.com.
authors.forename: Shridevi
authors.initials: S
authors.lastname: Subramaniam
authors.forename: Jamalia
authors.initials: J
authors.lastname: Rahmat
authors.forename: Norazah Abdul
authors.initials: NA
authors.lastname: Rahman
authors.forename: Sunder
authors.initials: S
authors.lastname: Ramasamy
authors.forename: Nirmala
authors.initials: N
authors.lastname: Bhoo-Pathy
authors.forename: Goh Pik
authors.initials: GP
authors.lastname: Pin
authors.forename: Joseph
authors.initials: J
authors.lastname: Alagaratnam
mesh_terms: D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008296:Malaysia / Q000453:epidemiology; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D019572:Retinal Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D012175:Retinoblastoma / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D015996:Survival Rate